Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort. [PDF]
Beach P, McKay JL.
europepmc +1 more source
The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. [PDF]
Palma JA +7 more
europepmc +1 more source
Management of coexistent neurogenic orthostatic hypotension and supine hypertension. [PDF]
Cannom DS.
europepmc +1 more source
Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension. [PDF]
Okamoto LE +7 more
europepmc +1 more source
Neglected cause of recurrent syncope: a case report of neurogenic orthostatic hypotension. [PDF]
Miller RJH, Chew DS, Raj SR.
europepmc +1 more source
[A case of neurogenic orthostatic hypotension].
openaire +1 more source
Cardiovascular medicines use in elderly population emphasis on blood pressure and serum lipids [PDF]
Tuikkala, Päivi
core
NEUROGENIC ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASE
Cardiovascular autonomic dysfunction is one of the most significant non-motor manifestations of Parkinson's disease (PD). Orthostatic hypotension (OH) holds a particular place in this context; it can be either symptomatic or asymptomatic and is associated with falls, impaired daily living activities, and reduced quality of life.
openaire +1 more source
Related searches:
Management of Neurogenic Orthostatic Hypotension
Journal of the American Medical Directors Association, 2014The burden of orthostatic hypotension (OH) on public health is a universally recognized enigmatic clinical condition that is associated with significant increases on morbidity and mortality rates, and can take a major toll on one's quality of life. Orthostatic hypotension is predictive of vascular deaths from acute myocardial infarction, strokes in the
Dennis J Cheek +2 more
exaly +3 more sources

